Immunogenicity and Safety of the Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (SP306) as a Booster in Japanese Adolescents
Phase of Trial: Phase I/II
Latest Information Update: 10 Mar 2016
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus First in man; Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Apr 2013 Planned end date changed from 1 Apr 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov record.
- 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.